These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7972021)
1. Ribozyme-mediated reversal of the multidrug-resistant phenotype. Scanlon KJ; Ishida H; Kashani-Sabet M Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11123-7. PubMed ID: 7972021 [TBL] [Abstract][Full Text] [Related]
2. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Scanlon KJ; Jiao L; Funato T; Wang W; Tone T; Rossi JJ; Kashani-Sabet M Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10591-5. PubMed ID: 1660142 [TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites. Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143 [TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. Kiehntopf M; Brach MA; Licht T; Petschauer S; Karawajew L; Kirschning C; Herrmann F EMBO J; 1994 Oct; 13(19):4645-52. PubMed ID: 7925305 [TBL] [Abstract][Full Text] [Related]
5. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA. Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Kowalski P; Stein U; Scheffer GL; Lage H Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458 [TBL] [Abstract][Full Text] [Related]
7. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Kobayashi H; Dorai T; Holland JF; Ohnuma T Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816 [TBL] [Abstract][Full Text] [Related]
8. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene. Qia S; Wang H; Chen X J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319 [TBL] [Abstract][Full Text] [Related]
9. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes. Bertram J; Palfner K; Killian M; Brysch W; Schlingensiepen KH; Hiddemann W; Kneba M Anticancer Drugs; 1995 Feb; 6(1):124-34. PubMed ID: 7756675 [TBL] [Abstract][Full Text] [Related]
10. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Holm PS; Scanlon KJ; Dietel M Br J Cancer; 1994 Aug; 70(2):239-43. PubMed ID: 7914421 [TBL] [Abstract][Full Text] [Related]
11. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines. Daly C; Coyle S; McBride S; O'Driscoll L; Daly N; Scanlon K; Clynes M Cytotechnology; 1996; 19(3):199-205. PubMed ID: 8862007 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
13. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme. Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514 [TBL] [Abstract][Full Text] [Related]
14. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]. Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561 [TBL] [Abstract][Full Text] [Related]
15. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Kim R; Beck WT Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863 [TBL] [Abstract][Full Text] [Related]
16. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. Chen XP; Wang Q; Guan J; Huang ZY; Zhang WG; Zhang BX World J Gastroenterol; 2006 Jun; 12(21):3332-7. PubMed ID: 16733848 [TBL] [Abstract][Full Text] [Related]
17. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Kobayashi H; Takemura Y; Miyachi H Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737 [TBL] [Abstract][Full Text] [Related]
18. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378 [TBL] [Abstract][Full Text] [Related]
19. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA. Cai DW; Mukhopadhyay T; Roth JA Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963 [TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme. Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]